MEDPHARM LIMITED

Company number 03783386

Date	Type	Description	View / Download
12 Mar 2021	PSC05	Change of details for Medpharm Holdco Limited as a person with significant control on 15 March 2018	(2 pages)
22 Feb 2021	AA	Full accounts made up to 31 December 2019	(31 pages)
12 Jan 2021	MR01	Registration of charge 037833860009, created on 4 January 2021	(14 pages)
12 Jan 2021	MR01	Registration of charge 037833860007, created on 4 January 2021	(30 pages)
12 Jan 2021	MR01	Registration of charge 037833860008, created on 4 January 2021	(13 pages)
13 Oct 2020	MR04	Satisfaction of charge 6 in full	(1 page)
14 Jun 2020	CS01	Confirmation statement made on 7 June 2020 with no updates	(3 pages)
09 Oct 2019	AA	Full accounts made up to 31 December 2018	(27 pages)
20 Jun 2019	CS01	Confirmation statement made on 7 June 2019 with no updates ANNOTATION Clarification a second filed CS01 (Statement of Capital and Shareholder Information) was registered on 26/07/2022.	(4 pages)
20 Jun 2019	AA01	Previous accounting period shortened from 31 July 2019 to 31 December 2018	(1 page)
14 Jun 2019	CH01	Director's details changed for David Parker on 1 May 2019	(2 pages)
14 Jun 2019	CH01	Director's details changed for David Parker on 1 May 2019	(2 pages)
03 May 2019	AA	Group of companies' accounts made up to 31 July 2018	(30 pages)
14 Dec 2018	AP01	Appointment of David Parker as a director on 8 December 2018	(2 pages)
14 Dec 2018	AP01	Appointment of Trevor Wahlbrink as a director on 8 December 2018	(2 pages)
03 Jul 2018	TM01	Termination of appointment of Simon Redgrove as a director on 1 May 2018	(1 page)
21 Jun 2018	CS01	07/06/18 Statement of Capital gbp 10024.4	(14 pages)
11 Apr 2018	SH01	Statement of capital following an allotment of shares on 13 March 2018 GBP 10,024.40	(10 pages)
10 Apr 2018	SH01	Statement of capital following an allotment of shares on 13 March 2018 GBP 9,846.70	(10 pages)
28 Mar 2018	PSC02	Notification of Medpharm Holdco Limited as a person with significant control on 15 March 2018	(2 pages)
28 Mar 2018	PSC07	Cessation of Andrew Gordon Muddle as a person with significant control on 15 March 2018	(1 page)
20 Mar 2018	TM01	Termination of appointment of Michael Nordsiek as a director on 15 March 2018	(1 page)
13 Mar 2018	MR04	Satisfaction of charge 3 in full	(1 page)
13 Mar 2018	MR04	Satisfaction of charge 2 in full	(1 page)
13 Mar 2018	MR04	Satisfaction of charge 4 in full	(1 page)